345 related articles for article (PubMed ID: 1879447)
21. Advances in cancer therapy with radiolabeled monoclonal antibodies.
Goldenberg DM; Sharkey RM
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):248-64. PubMed ID: 17043623
[TBL] [Abstract][Full Text] [Related]
22. Radionuclides in oncology clinical practice - review of the literature.
Luna Pais H; Alho I; Vendrell I; Mansinho A; Costa L
Dalton Trans; 2017 Oct; 46(42):14475-14487. PubMed ID: 28975182
[TBL] [Abstract][Full Text] [Related]
23. Advances in nuclear oncology: microspheres for internal radionuclide therapy of liver tumours.
Nijsen JF; van het Schip AD; Hennink WE; Rook DW; van Rijk PP; de Klerk JM
Curr Med Chem; 2002 Jan; 9(1):73-82. PubMed ID: 11860349
[TBL] [Abstract][Full Text] [Related]
24. Monte Carlo Calculation of Radioimmunotherapy with (90)Y-, (177)Lu-, (131)I-, (124)I-, and (188)Re-Nanoobjects: Choice of the Best Radionuclide for Solid Tumour Treatment by Using TCP and NTCP Concepts.
Lucas S; Feron O; Gallez B; Masereel B; Michiels C; Vander Borght T
Comput Math Methods Med; 2015; 2015():284360. PubMed ID: 26136812
[TBL] [Abstract][Full Text] [Related]
25. Perspectives on cancer therapy with radiolabeled monoclonal antibodies.
Sharkey RM; Goldenberg DM
J Nucl Med; 2005 Jan; 46 Suppl 1():115S-27S. PubMed ID: 15653660
[TBL] [Abstract][Full Text] [Related]
26. Radioimmunotherapy with alpha-particle emitting radionuclides.
Zalutsky MR; Pozzi OR
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
[TBL] [Abstract][Full Text] [Related]
27. The use of radionuclides for tumor therapy.
Fawwaz RA; Wang TS; Srivastava SC; Hardy MA
Int J Rad Appl Instrum B; 1986; 13(4):429-36. PubMed ID: 3793498
[TBL] [Abstract][Full Text] [Related]
28. Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends.
Steiner M; Neri D
Clin Cancer Res; 2011 Oct; 17(20):6406-16. PubMed ID: 22003068
[TBL] [Abstract][Full Text] [Related]
29. Basic immunology of antibody targeted radiotherapy.
Wong JY
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S8-14. PubMed ID: 16979446
[TBL] [Abstract][Full Text] [Related]
30. Systemic targeted radionuclide therapy: potential new areas.
Wong JY
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S74-82. PubMed ID: 16979445
[TBL] [Abstract][Full Text] [Related]
31. Radionuclide therapy in the United Kingdom in 1995.
Clarke SE; Clarke DG; Prescod N
Nucl Med Commun; 1999 Aug; 20(8):711-7. PubMed ID: 10451879
[TBL] [Abstract][Full Text] [Related]
32. Horizons in radionuclide therapy: 1985 update.
Beierwaltes WH
J Nucl Med; 1985 Apr; 26(4):421-7. PubMed ID: 3884750
[TBL] [Abstract][Full Text] [Related]
33. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
[TBL] [Abstract][Full Text] [Related]
34. Clinical applications of newer radionuclide therapies.
Brans B; Linden O; Giammarile F; Tennvall J; Punt C
Eur J Cancer; 2006 May; 42(8):994-1003. PubMed ID: 16564689
[TBL] [Abstract][Full Text] [Related]
35. Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002.
de Jong M; Kwekkeboom D; Valkema R; Krenning EP
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):463-9. PubMed ID: 12569416
[TBL] [Abstract][Full Text] [Related]
36. Radioimmunotherapy of prostate cancer.
Smith-Jones PM
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):297-304. PubMed ID: 15640793
[TBL] [Abstract][Full Text] [Related]
37. Endoradiotherapy in cancer treatment--basic concepts and future trends.
Zoller F; Eisenhut M; Haberkorn U; Mier W
Eur J Pharmacol; 2009 Dec; 625(1-3):55-62. PubMed ID: 19836381
[TBL] [Abstract][Full Text] [Related]
38. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
39. Role of radiation therapy in ovarian cancer.
Moore DH
Curr Opin Obstet Gynecol; 1990 Feb; 2(1):64-8. PubMed ID: 2102308
[No Abstract] [Full Text] [Related]
40. Radioimmunoconjugates. Targeting disease for diagnosis and treatment.
Tilyou SM
J Nucl Med; 1990 Dec; 31(12):15A-20A, 30A. PubMed ID: 2266383
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
